𝔖 Bobbio Scriptorium

✦ LIBER ✦

TCT-232: First In Man Application Of Bevacizumab Eluting Stent: Long Term Results Of a Novel Approach for The Inhibition Of Plaque Neovascularization

Book ID: 119269709
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 154 KB
Volume: 56
Category: Article
ISSN: 1558-3597
DOI: 10.1016/j.jacc.2010.08.256

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

TCT-386: First In Man Application Of Bev

TCT-386: First In Man Application Of Bevacizumab Eluting Stent:a Novel Approach For The Inhibition Of Plaque Neovascularization. Long Term Results

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 213 KB

TCT-229: First Report of A Novel Polymer

TCT-229: First Report of A Novel Polymer-Free Dual-Drug Eluting Stent in De Novo Coronary Artery Disease: Results of the First in Man BICARE Trial

📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 110 KB

TCT-242: First Report of A Novel Ablumin

TCT-242: First Report of A Novel Abluminal Groove Filled Biodegradable Polymer Rapamycin-Eluting Stent in De Novo Coronary Artery Disease: Results of the First in Man FIREHAWK Trial

📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 213 KB